ISSN 1178-6191

Maori Health Review

Making Education Easy Issue 108 – 2024

Maori Health Review

Access to and timeliness of lung cancer surgery, radiation therapy, and systemic therapy in New Zealand

Authors: Gurney J et al.

Summary: Māori patients who may be good candidates for lung cancer surgery are less likely to receive this treatment than their European counterparts, according to a national study. All 27,689 lung cancer registrations over the period 2007 to 2019 were analysed, of whom 14% of Māori patients and 20% of European patients accessed surgery (adjusted odds ratio 0.82 (95% confidence interval [CI] 0.73–0.92]). Corresponding rates for accessing curative surgery were 10% of Māori and 16% of European patients (adjusted odds ratio 0.72; 95% CI 0.62 0.84). Differences in access could only partially be explained by cancer stage and comorbidities. After adjustment for age, there were no differences in access to radiation therapy or systemic therapy. There appeared to be a longer time from diagnosis to radiation therapy for Māori compared with European patients, but the difference was small and requires further investigation.

Reference: JCO Glob Oncol. 2024;10:e2300258.

Abstract

Equity of travel to access surgery and radiation therapy for lung cancer in New Zealand

Authors: Gurney J et al.

Summary: A further analysis of the national lung cancer registration dataset for 2007 to 2019 has found that Māori patients need to travel longer than European patients to access surgery and radiation therapy. The median travel distances for Māori vs European patients were 57 vs 34 km to access surgery and 75 vs 35 km to access radiation therapy. The adjusted odds of living more than 200 km away for Māori patients was 1.83 (95% CI 1.49–2.25) for surgery and 1.41 (95% CI 1.25–1.60) for radiation therapy compared with European patients. The study authors commented that while centralisation of care may improve treatment outcomes, it also makes accessing treatment more difficult for populations such as Māori who are more likely to live rurally and in deprivation.

Comment: As the authors say, lung cancer is the biggest cancer killer of Māori and so I am somewhat surprised that it has taken this long to evaluate the care pathway to the extent it has been in these papers. I’ve spoken before about the stigma of lung cancer (often associated with smoking) when we know about the differential exposure to other risk factors (i.e. occupational) between Māori and non-Māori. And now we have evidence for inequitable lung cancer treatment. The lung cancer screening programme, currently being tested for Māori and Pacific peoples, holds promise.

Reference: Support Care Cancer. 2024;32(3):171.

Abstract

Privacy Policy: Research Review will record your email details on a secure database and will not release them to anyone without your prior approval. Research Review and you have the right to inspect, update or delete your details at any time. The views expressed in this Publication are personal to the authors, and do not necessarily represent the views or policy of the Ministry of Health on the issues dealt with in the publication.

Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.

Research Review publications are intended for New Zealand health professionals.

The impact of Covid-19 vaccination in Aotearoa New Zealand

Authors: Datta S et al.

Summary: COVID-19 vaccination greatly reduced the health burden in New Zealand, according to a mathematical model used by the government, but equity needs to be a focus of future vaccination programmes. The model included age- and time-dependent case ascertainment, the effect of antiviral medications, improved hospitalisation rate estimates, and the impact of relaxing control measures. Analyses found that vaccines saved 6650 (95% credible interval [Crl] 4424–10,180) lives, prevented 74,500 (Crl 51,000–115,400) years of life lost and prevented 45,100 (Crl 34,400–55,600) hospitalisations over the period January 2022 to June 2023. Vaccination rates were lower in Māori than people of European ethnicity; results showed that equitable vaccination rates could have prevented an estimated 11%-26% of the 292 Māori COVID-19 deaths recorded over this time period.

Comment: I still have people contact me about my pro-COVID 19 vaccination stance, sending through misinformation and attempting to persuade me to change views. I will be sending them this paper and highlighting the statement showing the number of Māori COVID-19 deaths that could have been prevented if vaccination rates had been equitable. Anā!

Reference: Vaccine. 2024;42(6):1383-1391.

Abstract

Maori Health Review
Maori Health Review